Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,000 | 2 | 75.8% |
| Travel and Lodging | $2,727 | 9 | 20.7% |
| Food and Beverage | $458.40 | 3 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $12,330 | 6 | $0 (2024) |
| GENZYME CORPORATION | $662.06 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $193.33 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,244 | 2 | PFIZER INC. ($7,244) |
| 2023 | $5,279 | 5 | PFIZER INC. ($5,086) |
| 2019 | $397.75 | 4 | GENZYME CORPORATION ($397.75) |
| 2018 | $264.31 | 3 | GENZYME CORPORATION ($264.31) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/01/2024 | PFIZER INC. | TALZENNA (Drug) | Travel and Lodging | Cash or cash equivalent | $243.97 | General |
| Category: ONCOLOGY | ||||||
| 01/04/2024 | PFIZER INC. | TALZENNA (Drug) | Consulting Fee | Cash or cash equivalent | $7,000.00 | General |
| Category: ONCOLOGY | ||||||
| 12/15/2023 | PFIZER INC. | TALZENNA (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: ONCOLOGY | ||||||
| 12/01/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $741.58 | General |
| 12/01/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $718.62 | General |
| 12/01/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $625.76 | General |
| 09/17/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $193.33 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $159.79 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $126.84 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $84.00 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $27.12 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $138.23 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $88.61 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $37.47 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 187 | 266 | $53,131 | $13,111 |
| 2022 | 7 | 201 | 272 | $67,264 | $15,827 |
| 2021 | 7 | 240 | 373 | $86,615 | $22,478 |
| 2020 | 6 | 123 | 184 | $46,426 | $11,629 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2023 | 59 | 59 | $15,562 | $3,869 | 24.9% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 31 | 44 | $11,204 | $2,944 | 26.3% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2023 | 16 | 16 | $11,189 | $2,256 | 20.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 32 | 56 | $6,419 | $1,725 | 26.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 22 | 61 | $5,447 | $1,449 | 26.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 27 | 30 | $3,310 | $867.99 | 26.2% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 32 | 54 | $14,260 | $3,782 | 26.5% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2022 | 50 | 50 | $13,762 | $3,480 | 25.3% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2022 | 19 | 20 | $17,143 | $2,835 | 16.5% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2022 | 15 | 17 | $7,949 | $1,996 | 25.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 37 | 57 | $6,859 | $1,842 | 26.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 23 | 45 | $4,063 | $1,027 | 25.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 25 | 29 | $3,228 | $865.53 | 26.8% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2021 | 50 | 95 | $24,797 | $6,807 | 27.5% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2021 | 52 | 53 | $14,337 | $3,838 | 26.8% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2021 | 24 | 24 | $17,364 | $3,582 | 20.6% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2021 | 17 | 24 | $11,036 | $3,057 | 27.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 46 | 89 | $10,529 | $2,834 | 26.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 23 | 56 | $5,006 | $1,386 | 27.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 28 | 32 | $3,546 | $974.70 | 27.5% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2020 | 28 | 55 | $14,421 | $4,024 | 27.9% |
| 88321 | Surgical pathology consultation and report | Facility | 2020 | 31 | 31 | $9,002 | $2,126 | 23.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 28 | 60 | $7,170 | $1,867 | 26.0% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2020 | 13 | 13 | $8,820 | $1,776 | 20.1% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2020 | 11 | 12 | $5,559 | $1,427 | 25.7% |
About Dr. Michael Haffner, M.D
Dr. Michael Haffner, M.D is a Anatomic Pathology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1629455464.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Haffner, M.D has received a total of $13,185 in payments from pharmaceutical and medical device companies, with $7,244 received in 2024. These payments were reported across 14 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($10,000).
As a Medicare-enrolled provider, Haffner has provided services to 751 Medicare beneficiaries, totaling 1,095 services with total Medicare billing of $63,044. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location Seattle, WA
- Active Since 04/30/2015
- Last Updated 11/18/2019
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1629455464
Products in Payments
- TALZENNA (Drug) $10,244
- NO PRODUCT DISCUSSED (Drug) $662.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Seattle
Dr. Monica De Baca, M.d, M.D
Anatomic Pathology — Payments: $322,586
Behzad Najafian, Md, MD
Anatomic Pathology — Payments: $85,163
Dr. Shreeram Akilesh, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $126.86
Ellen Pizer, Md Phd, MD PHD
Anatomic Pathology — Payments: $121.95
Nuria Perez-Reyes, Md, MD
Anatomic Pathology — Payments: $121.95
Haodong Xu, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $102.96